Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects.
暂无分享,去创建一个
P. Libby | F. Jaffer | G. Reed | M. Jaff | Hang Lee | A. Tawakol | P. Henke | M. Orii | I. Weinberg | C. Kessinger | Wenzhu Li | Lang Wang
[1] L. Kroft,et al. Diagnosis of suspected recurrent ipsilateral deep vein thrombosis with magnetic resonance direct thrombus imaging. , 2020, Blood.
[2] S. Goldhaber,et al. Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis , 2020 .
[3] P. Henke,et al. Acute experimental venous thrombosis impairs venous relaxation but not contraction. , 2020, Journal of vascular surgery.
[4] J. Weitz,et al. Novel Antithrombotic Strategies for Treatment of Venous Thromboembolism. , 2020, Blood.
[5] J. Kaufman,et al. Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis. , 2020, Journal of vascular surgery. Venous and lymphatic disorders.
[6] L. Tick,et al. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. , 2019, The Lancet. Haematology.
[7] J. Raffetto,et al. Sulodexide Improves Contraction and Decreases Matrix Metalloproteinase-2 and -9 in Veins under Prolonged Stretch. , 2019, Journal of cardiovascular pharmacology.
[8] S. Goldhaber,et al. Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial , 2019, Vascular medicine.
[9] R. Sarkar,et al. Fibrinolysis and Inflammation in Venous Thrombus Resolution , 2019, Front. Immunol..
[10] Alberto Smith,et al. Choosing a Mouse Model of Venous Thrombosis. , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[11] J. Giri,et al. Reexamining the Open-Vein Hypothesis for Acute Deep Venous Thrombosis , 2019, Circulation.
[12] R. Winokur,et al. DVT Intervention in the Post-ATTRACT Era , 2018, Current Treatment Options in Cardiovascular Medicine.
[13] S. Goldhaber,et al. Pharmacomechanical Catheter‐Directed Thrombolysis for Deep‐Vein Thrombosis , 2017, The New England journal of medicine.
[14] S. Partovi,et al. Can thrombus age guide thrombolytic therapy? , 2017, Cardiovascular diagnosis and therapy.
[15] A. Chandrashekar,et al. Vein wall remodeling in patients with acute deep vein thrombosis and chronic postthrombotic changes , 2017, Journal of thrombosis and haemostasis : JTH.
[16] A. Schmaier,et al. Myeloid-related protein-14 regulates deep vein thrombosis. , 2017, JCI insight.
[17] V. Gurewich. Therapeutic Fibrinolysis: How Efficacy and Safety Can Be Improved. , 2016, Journal of the American College of Cardiology.
[18] T. Wakefield,et al. The post thrombotic syndrome: Ignore it and it will come back to bite you. , 2016, Blood reviews.
[19] Alberto Smith,et al. Assessment of Venous Thrombosis in Animal Models , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[20] L. Sandvik,et al. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. , 2016, The Lancet. Haematology.
[21] M. Cushman,et al. Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis. , 2015, Journal of vascular surgery. Venous and lymphatic disorders.
[22] Charles P. Lin,et al. Blood Accessibility to Fibrin in Venous Thrombosis is Thrombus Age-Dependent and Predicts Fibrinolytic Efficacy: An In Vivo Fibrin Molecular Imaging Study , 2015, Theranostics.
[23] P. Henke,et al. A histological and functional description of the tissue causing chronic postthrombotic venous obstruction. , 2015, Thrombosis research.
[24] Charles P. Lin,et al. Statins Improve the Resolution of Established Murine Venous Thrombosis: Reductions in Thrombus Burden and Vein Wall Scarring , 2015, PloS one.
[25] R. Weissleder,et al. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Enables the Detection of Recurrent Same-Site Deep Vein Thrombosis by Illuminating Recently Formed, Neutrophil-Rich Thrombus , 2014, Circulation.
[26] Vassilios J. Bezzerides,et al. Abstract 238: miR-222 is Necessary for Exercise-induced Cardiac Growth and Protects Against Pathological Cardiac Remodeling , 2014 .
[27] P. Libby,et al. Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development , 2014, Journal of thrombosis and haemostasis : JTH.
[28] René M. Botnar,et al. Fibrin-Targeted Magnetic Resonance Imaging Allows In Vivo Quantification of Thrombus Fibrin Content and Identifies Thrombi Amenable for Thrombolysis , 2014, Arteriosclerosis, Thrombosis and Vascular Biology.
[29] N. Mackman,et al. Strengths and weaknesses of a new mouse model of thrombosis induced by inferior vena cava stenosis: communication from the SSC of the ISTH , 2014, Journal of thrombosis and haemostasis : JTH.
[30] F. Jaffer,et al. Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT. , 2013, Thrombosis research.
[31] T. Wakefield,et al. The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse , 2013, Thrombosis and Haemostasis.
[32] T. Wakefield,et al. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis. , 2012, Journal of vascular surgery.
[33] Charles P. Lin,et al. Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence. , 2012, JACC. Cardiovascular imaging.
[34] T. Wakefield,et al. Critical review of mouse models of venous thrombosis. , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[35] L. Sandvik,et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial , 2012, The Lancet.
[36] Anetta Undas,et al. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[37] J. Kline,et al. Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Association , 2011, Circulation.
[38] S. Vedantham,et al. The Role of Thrombolysis in the Clinical Management of Deep Vein Thrombosis , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[39] Alberto Smith,et al. Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions. , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[40] P. Henke,et al. The vessel wall: A forgotten player in post thrombotic syndrome , 2010, Thrombosis and Haemostasis.
[41] T. Wakefield,et al. Thrombogenesis with continuous blood flow in the inferior vena cava , 2010, Thrombosis and Haemostasis.
[42] S. Kahn. How I treat postthrombotic syndrome. , 2009, Blood.
[43] G. Chavhan,et al. Normal Doppler spectral waveforms of major pediatric vessels: specific patterns. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.
[44] T. Wakefield,et al. Mechanisms of venous thrombosis and resolution. , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[45] Andrea J. Moore,et al. Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis , 2007, Thrombosis and Haemostasis.
[46] Daniel M. Oppenheimer,et al. Correlated Averages vs. Averaged Correlations: Demonstrating the Warm Glow Heuristic Beyond Aggregation. , 2005 .
[47] Andrea J. Moore,et al. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. , 2005, Journal of vascular surgery.
[48] S. Schroter,et al. Evaluation of outcomes in chronic venous disorders of the leg: development of a scientifically rigorous, patient-reported measure of symptoms and quality of life. , 2003, Journal of vascular surgery.
[49] J. Mehta,et al. Inhibition of arterial thrombus formation by ApoA1 Milano. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[50] M. Armon,et al. Thrombolysis for acute deep vein thrombosis , 1996, The Cochrane database of systematic reviews.
[51] R. Schmutzler. [The treatment of deep venous thrombosis. Thrombolysis vs heparin]. , 1990, Phlebologie.
[52] R. Paulson. Treatment of deep venous thrombosis. , 1986, Mayo Clinic proceedings.
[53] C. Korninger,et al. Studies on the Specific Fibrinolytic Effect of Human Extrinsic (Tissue-Type) Plasminogen Activator in Human Blood and in Various Animal Species in Vitro , 1981, Thrombosis and Haemostasis.
[54] H. Moore,et al. Scoring systems for the post-thrombotic syndrome. , 2013, Journal of vascular surgery.
[55] T. Wakefield,et al. Postthrombotic vein wall remodeling: preliminary observations. , 2011, Journal of vascular surgery.